Literature DB >> 8047379

Developmental changes of phosphorus metabolite concentrations in the human brain: a 31P magnetic resonance spectroscopy study in vivo.

R Buchli1, E Martin, P Boesiger, H Rumpel.   

Abstract

Phosphorus magnetic resonance spectroscopy is a noninvasive method to investigate brain metabolism in vivo. ATP generally serves as an internal concentration standard for the quantification of the various phosphorus metabolites, because the ATP concentration in mammalian brains is assumed to be age independent. This presumption is based on observations made in the biochemical analysis of the developing rat brain. In the present study, metabolite concentrations were assessed with an external concentration standard. Each brain spectrum was quantified using a calibration spectrum that was acquired from a phantom after the in vivo brain measurement. Fully relaxed localized brain spectra were obtained from 16 neonates (2-28 d), 17 infants (6-20 mo), and 28 adults (22-58 y). The metabolite concentrations (in mmol/L) changed from neonates to adults: phosphomonoester from 4.5 to 3.5, inorganic phosphate from 0.6 to 1.0, phosphodiester from 3.2 to 11.7, phosphocreatine from 1.4 to 3.4, and ATP from 1.6 to 2.9. We conclude that 1) the ATP concentration in the human brain almost doubles between neonates and adults, and 2) ATP may not be used as an age-independent internal concentration standard.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8047379

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  9 in total

1.  Metabolite concentrations and relaxation in perinatal cerebral hypoxic-ischemic injury.

Authors:  E B Cady
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

2.  Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia.

Authors:  A D Hinsberger; P C Williamson; T J Carr; J A Stanley; D J Drost; M Densmore; G C MacFabe; D G Montemurro
Journal:  J Psychiatry Neurosci       Date:  1997-03       Impact factor: 6.186

3.  Evidence of developmental alterations in cortical and subcortical regions of children with attention-deficit/hyperactivity disorder: a multivoxel in vivo phosphorus 31 spectroscopy study.

Authors:  Jeffrey A Stanley; Heidi Kipp; Erika Greisenegger; Frank P MacMaster; K Panchalingam; Matcheri S Keshavan; Oscar G Bukstein; Jay W Pettegrew
Journal:  Arch Gen Psychiatry       Date:  2008-12

4.  Molecular neurodevelopment: an in vivo 31P-1H MRSI study.

Authors:  Gerald Goldstein; Kanagasabai Panchalingam; Richard J McClure; Jeffrey A Stanley; Vince D Calhoun; Godfrey D Pearlson; Jay W Pettegrew
Journal:  J Int Neuropsychol Soc       Date:  2009-08-13       Impact factor: 2.892

5.  Functional energetic responses and individual variance of the human brain revealed by quantitative imaging of adenosine triphosphate production rates.

Authors:  Xiao-Hong Zhu; Byeong-Yeul Lee; Wei Chen
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-10       Impact factor: 6.200

Review 6.  Na⁺/H⁺ exchangers and intracellular pH in perinatal brain injury.

Authors:  Cristina Uria-Avellanal; Nicola J Robertson
Journal:  Transl Stroke Res       Date:  2014-01-24       Impact factor: 6.829

7.  Cerebral phosphoester signals measured by 31P magnetic resonance spectroscopy at 3 and 7 Tesla.

Authors:  Shizhe Li; Jan Willem van der Veen; Li An; JoEllyn Stolinski; Christopher Johnson; Maria Ferraris-Araneta; Milalynn Victorino; Jyoti Singh Tomar; Jun Shen
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

8.  Oxidative phosphorylation in creatine transporter deficiency.

Authors:  Shizhe Li; Simona Bianconi; Jan Willem van der Veen; An Dang Do; JoEllyn Stolinski; Kim M Cecil; Fady Hannah-Shmouni; Forbes D Porter; Jun Shen
Journal:  NMR Biomed       Date:  2020-09-29       Impact factor: 4.478

9.  Influence of phosphate concentration on amine, amide, and hydroxyl CEST contrast.

Authors:  Jingwen Yao; Chencai Wang; Benjamin M Ellingson
Journal:  Magn Reson Med       Date:  2020-09-16       Impact factor: 3.737

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.